Trial Profile
RTaxot: Docetaxel-based concurrent chemo-hormono-radiation in high and very high-risk prostate cancer patients: a phase II multicenter trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms RTaxot
- 30 Jun 2014 New trial record